T polyclonal Frontier Institute, VGluT2-Rb-Af720, rabbit polyclonal 2 mg/ml for

T polyclonal Frontier Institute, VGluT2-Rb-Af720, rabbit polyclonal 2 mg/ml for immunohistochemistry, 0.5 mg/ml for western blot 1:500 2 mg/ml 2 mg/ml 2 mg/ml 2 mg/ml 0.05 mg/mlGlyceraldehyde-3-phosphate dehydrogenase Millipore, MAB374, mouse monoclonal from rabbit muscledoi:10.1371/journal.pone.0053082.tRegulation of CB1 Expression in Mouse 38916-34-6 manufacturer VFigure 1. Distribution of CB1 in the visual cortex. (A) Low-magnification image of a coronal section of mouse brain at P30, immunostained for CB1. Inset, magnified view of LGN (*). Scale, 1 mm and 250 mm (inset). (B) Layer distribution of CB1 immunoreactivity in V1 (CB1). Layer boundaries were determined in neighboring Nissl-stained sections (Nissl). Scale, 100 mm. (C) Regional distribution of CB1 immunoreactivity in the visual cortex. Arrowheads indicate the boundaries between V1 and V2, determined in Nissl-stained sections. V2M: secondary visual cortex medial area, V2L: secondary visual cortex lateral area, MR: monocular region, BR: binocular region. Scale, 500 mm. (D) Horizontal profiles of CB1 immunoreactivity across the visual cortex. Signal intensity was measured in layer II/III. Dotted lines indicate region boundaries. The gray lines represent the profiles in individual sections obtained from an animal, and the black line represents the mean of them. AU indicates arbitrary units. (E) Mean signal intensity of CB1 in each visual cortical region. The error bars indicate SEM (n = 5 animals, one-way repeated measured ANOVA, p,0.05, post hoc Tukey’s test, *: p,0.05). doi:10.1371/journal.pone.0053082.gblocking solution for 4? hr and then in a secondary antibody solution (1:200, species-specific biotinylated antibody (Vector Laboratories) in blocking solution) overnight at 4uC. They were then reacted using the conventional ABC-DAB method. All sections were mounted 23977191 onto MAS-coated slides, dehydrated in an ascending series of ethanol, defatted in xylene, and coverslipped with DPX mountant (SIGMA). For immunofluorescence, sections were incubated in a blocking solution (5 donkey serum (Jackson ImmunoReseach), 5 BSA, 0.5 Triton X-100 in PBS) for 1? hr at room temperature. They were incubated in the blocking solution containing the primary antibodies overnight at 4uC. After washing in PBS, the sections were incubated in a secondary antibody solution (1:200, Alexa 488-conjugated or Alexa 568-conjugated species specific antibodies (Life Technologies) in the blocking solution) for 2? hr at room temperature. After washing, the sections were mounted on MAS-coated slides and coverslipped with Fluoromount/plus (Diagnostic Biosystems).Image AnalysisImage analyses were performed using the ImageJ software. Images for horizontal and layer profile analyses of CB1 immunoreactivity in the visual cortex were captured using a cooled CCD Solvent Yellow 14 site camera (VB-7010, Keyence). To measure the horizontal profile of CB1 immunoreactivity, regions of interest (ROIs) wereset on layer II/III across cortical areas. Signal intensity was measured in 12 images from 5 animals. To measure the layer profiles of signal intensity for CB1, ROIs (200 mm6800 mm) were set on layer II-VI of the binocular region of V1. CB1 immunoreactivities were measured in 12?0 sites from 3? animals in each age group. Layer and region boundaries were defined in neighboring Nissl- or DAPI-stained sections. For the synaptic localization analysis of CB1, images were acquired with laser confocal microscopy (TCS SP2, Leica Microsystems). Images were obtained using a 636 oi.T polyclonal Frontier Institute, VGluT2-Rb-Af720, rabbit polyclonal 2 mg/ml for immunohistochemistry, 0.5 mg/ml for western blot 1:500 2 mg/ml 2 mg/ml 2 mg/ml 2 mg/ml 0.05 mg/mlGlyceraldehyde-3-phosphate dehydrogenase Millipore, MAB374, mouse monoclonal from rabbit muscledoi:10.1371/journal.pone.0053082.tRegulation of CB1 Expression in Mouse VFigure 1. Distribution of CB1 in the visual cortex. (A) Low-magnification image of a coronal section of mouse brain at P30, immunostained for CB1. Inset, magnified view of LGN (*). Scale, 1 mm and 250 mm (inset). (B) Layer distribution of CB1 immunoreactivity in V1 (CB1). Layer boundaries were determined in neighboring Nissl-stained sections (Nissl). Scale, 100 mm. (C) Regional distribution of CB1 immunoreactivity in the visual cortex. Arrowheads indicate the boundaries between V1 and V2, determined in Nissl-stained sections. V2M: secondary visual cortex medial area, V2L: secondary visual cortex lateral area, MR: monocular region, BR: binocular region. Scale, 500 mm. (D) Horizontal profiles of CB1 immunoreactivity across the visual cortex. Signal intensity was measured in layer II/III. Dotted lines indicate region boundaries. The gray lines represent the profiles in individual sections obtained from an animal, and the black line represents the mean of them. AU indicates arbitrary units. (E) Mean signal intensity of CB1 in each visual cortical region. The error bars indicate SEM (n = 5 animals, one-way repeated measured ANOVA, p,0.05, post hoc Tukey’s test, *: p,0.05). doi:10.1371/journal.pone.0053082.gblocking solution for 4? hr and then in a secondary antibody solution (1:200, species-specific biotinylated antibody (Vector Laboratories) in blocking solution) overnight at 4uC. They were then reacted using the conventional ABC-DAB method. All sections were mounted 23977191 onto MAS-coated slides, dehydrated in an ascending series of ethanol, defatted in xylene, and coverslipped with DPX mountant (SIGMA). For immunofluorescence, sections were incubated in a blocking solution (5 donkey serum (Jackson ImmunoReseach), 5 BSA, 0.5 Triton X-100 in PBS) for 1? hr at room temperature. They were incubated in the blocking solution containing the primary antibodies overnight at 4uC. After washing in PBS, the sections were incubated in a secondary antibody solution (1:200, Alexa 488-conjugated or Alexa 568-conjugated species specific antibodies (Life Technologies) in the blocking solution) for 2? hr at room temperature. After washing, the sections were mounted on MAS-coated slides and coverslipped with Fluoromount/plus (Diagnostic Biosystems).Image AnalysisImage analyses were performed using the ImageJ software. Images for horizontal and layer profile analyses of CB1 immunoreactivity in the visual cortex were captured using a cooled CCD camera (VB-7010, Keyence). To measure the horizontal profile of CB1 immunoreactivity, regions of interest (ROIs) wereset on layer II/III across cortical areas. Signal intensity was measured in 12 images from 5 animals. To measure the layer profiles of signal intensity for CB1, ROIs (200 mm6800 mm) were set on layer II-VI of the binocular region of V1. CB1 immunoreactivities were measured in 12?0 sites from 3? animals in each age group. Layer and region boundaries were defined in neighboring Nissl- or DAPI-stained sections. For the synaptic localization analysis of CB1, images were acquired with laser confocal microscopy (TCS SP2, Leica Microsystems). Images were obtained using a 636 oi.